ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Nephrology · Kidney Int · 2026-03-27

In 49 patients with lupus nephritis in clinical remission and asymptomatic serological reactivation, a pre-emptive moderate rise in immunosuppression vs observation gave 24-month kidney flare-free survival of 100% vs 80%; adverse events were few and similar.

RCTn = 49
Yap et al. A prospective multicenter randomized controlled trial pre-emptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.